Additional Details
-
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteCharleston SC. 29425View Details -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteBirmingham AL. 35233View Details -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteIowa City IA. 52242View Details -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteDenver CO. 80206View Details -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SitePhiladelphia PA. 19140View Details -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteNew York NY. 10029View Details -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteChicago IL. 60611View Details -
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria Investigative SiteGreenville NC. 27858View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteWashington D.C. DC. 20007View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteMiami FL. 33144View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteLos Angeles CA. 90301View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteJacksonville FL. 32610View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteNew York NY. 11201View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteDenison TX. 75020View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteEl Paso TX. 79902View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SitePhiladelphia PA. 19104View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteAnn Arbor MI. 48109View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SitePhiladelphia PA. 19140View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteTucson AZ. 85724View Details
